Resistance to Targeted-TKI Treatment in Patients With CML Targeted Oncology 6:51 5 years ago 428 Далее Скачать
Understanding the cause of TKI resistance to improve management strategies in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:45 2 years ago 211 Далее Скачать
Addressing the issue of resistance to TKIs in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:11 2 years ago 80 Далее Скачать
Targeting TKI-resistant CML with LY3009120 and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 2:40 3 years ago 387 Далее Скачать
Emerging therapeutic approaches for TKI-resistant CML VJHemOnc – Video Journal of Hematology & HemOnc 1:39 2 years ago 136 Далее Скачать
Mechanisms of resistance to the TKI asciminib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:16 3 months ago 95 Далее Скачать
Outcomes of patients with CML with no molecular response within two years of TKI therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:32 1 year ago 844 Далее Скачать
Efficacy & tolerability of available TKI therapies in CML & managing TKI resistance VJHemOnc – Video Journal of Hematology & HemOnc 6:22 2 years ago 68 Далее Скачать
Novel treatment strategies for patients with CML who are intolerant or resistant to available TKIs VJHemOnc – Video Journal of Hematology & HemOnc 2:00 2 years ago 93 Далее Скачать
CML as an Ideal Cancer for Targeted Therapy With TKI Targeted Oncology 7:32 5 years ago 375 Далее Скачать
The role of CML stem cells in relapse after TKI discontinuation & resistance to treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:12 2 years ago 156 Далее Скачать
Unmet needs in CML: life-threatening toxicities, QoL & dealing with intolerance and resistance VJHemOnc – Video Journal of Hematology & HemOnc 1:30 2 years ago 64 Далее Скачать
CML: Rationale for Mutation Testing and TKI Therapy Targeted Oncology 3:46 7 years ago 136 Далее Скачать
Downregulation of MS4A3 promotes TKI resistance in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:42 3 years ago 52 Далее Скачать
TKI Resistance: More than just Abl mutations International CML Foundation 30:10 1 year ago 97 Далее Скачать
How do we recognize treatment failure or treatment resistance? MediCom Oncology 3:56 8 years ago 64 Далее Скачать
Response Monitoring of Patients With CML Treated With TKIs Targeted Oncology 8:01 5 years ago 108 Далее Скачать
Unmet needs in CML: dealing with resistance and progression, pregnancy, QoL & access to treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:11 2 years ago 65 Далее Скачать
